Company intelligence / Profile preview

Qingdao East Sea Pharmaceutical Co., Ltd.

Ownership: Private
Development stage: Other

Overview

Qingdao East Sea Pharmaceutical is a leading Chinese company specializing in the research, production, and commercialization of microecological drugs—primarily live probiotic products such as Clostridium butyricum and Bacillus coagulans. Their products are approved for use in China to treat various gastrointestinal disorders including IBS, diarrhea, constipation, ulcerative colitis, and Crohn’s disease. The company has broken international monopolies on certain probiotic strains and holds multiple patents related to their formulations. Clinical trials have demonstrated efficacy for IBS treatment.[6][8]

Therapeutic areas: Gastroenterology
Modalities: Probiotics (live bacterial therapeutics)Microecological drugs (e.g., Clostridium butyricum, Bacillus coagulans)
Industry: Biotech

Drug pipeline

2 assets

bacillus coagulans TBC169

Preclinical

1 more asset in the full pipeline.

Beyond the preview

Go deeper on Qingdao East Sea Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingdao East Sea Pharmaceutical Co., Ltd..